BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30917950)

  • 1. Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis.
    Barker JN; Boughan K; Dahi PB; Devlin SM; Maloy MA; Naputo K; Mazis CM; Davis E; Nhaissi M; Wells D; Cooper C; Ponce DM; Kernan N; Scaradavou A; Giralt SA; Papadopoulos EB; Politikos I
    Blood Adv; 2019 Apr; 3(7):939-944. PubMed ID: 30917950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities.
    Barker JN; Byam CE; Kernan NA; Lee SS; Hawke RM; Doshi KA; Wells DS; Heller G; Papadopoulos EB; Scaradavou A; Young JW; van den Brink MR
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1541-8. PubMed ID: 20800103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation.
    Fingrut WB; Davis E; Archer A; Brown S; Devlin S; Nhaissi M; Rapoport C; Chinapen S; Kelly A; Wells D; Scaradavou A; Gyurkocza B; Papadopoulos E; Politikos I; Shaffer BC; Barker JN
    Blood Adv; 2024 Jun; 8(11):2753-2764. PubMed ID: 38429097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B-Cell acute lymphoblastic leukemia.
    Segal E; Martens M; Wang HL; Brazauskas R; Weisdorf D; Sandmaier BM; Khoury HJ; de Lima M; Saber W
    Cancer; 2017 Sep; 123(17):3346-3355. PubMed ID: 28452054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Resolution Match Rate of 7/8 and 9/10 or Better for the Be The Match Unrelated Donor Registry.
    Buck K; Wadsworth K; Setterholm M; Maiers M; Confer D; Hartzman R; Schmidt A; Yang SY; Dehn J
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):759-763. PubMed ID: 26724431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor.
    Ringdén O; Okas M; Uhlin M; Uzunel M; Remberger M; Mattsson J
    Bone Marrow Transplant; 2008 Nov; 42(10):643-8. PubMed ID: 18762760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection.
    Kosuri S; Wolff T; Devlin SM; Byam C; Mazis CM; Naputo K; Davis E; Paulson J; Nhaissi M; Wells DS; Dahi P; Giralt SA; Jakubowski A; Perales MA; Shaffer BC; Scaradavou A; Ponce DM; Barker JN
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):965-970. PubMed ID: 28263918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a 10/10 matched donor for patients with an uncommon haplotype is unlikely.
    Olson JA; Gibbens Y; Tram K; Kempenich J; Novakovich J; Buck K; Dehn J
    HLA; 2017 Feb; 89(2):77-81. PubMed ID: 28102042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search Initiation.
    Davis E; Devlin S; Cooper C; Nhaissi M; Paulson J; Wells D; Scaradavou A; Giralt S; Papadopoulos E; Kernan NA; Byam C; Barker JN
    Biol Blood Marrow Transplant; 2018 May; 24(5):1057-1062. PubMed ID: 29287807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia.
    Fingrut WB; Gyurkocza B; Flynn J; Davis E; Devlin S; Scaradavou A; Chinapen S; Quach S; Cho C; Giralt SA; Jakubowski AA; Lin RJ; Papadopoulos EB; Perales MA; Ponce D; Shaffer BC; Tamari R; Young JW; Politikos I; Barker JN
    Blood Adv; 2023 Aug; 7(15):3824-3833. PubMed ID: 36240477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding donor options: haploidentical transplant recipients are also highly likely to have a 7/8-matched unrelated donor.
    Fingerson S; Maiers M; Bolon YT; Devine SM; Spellman SR
    Blood Adv; 2024 Feb; 8(3):758-765. PubMed ID: 38127270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-C disparity between patients and unrelated donors matched for HLA-A, -B, and -DRB1 alleles: impact of serological vs. DNA typing for HLA-A and -B loci.
    Prasad VK; Kernan NA; Heller G; O'Reilly RJ; Yang SY
    Biol Blood Marrow Transplant; 1999; 5(2):77-85. PubMed ID: 10371359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allocation to Matched Related or Unrelated Donor Results in Similar Clinical Outcomes without Increased Risk of Failure to Proceed to Transplant among Patients with Acute Myeloid Leukemia: A Retrospective Analysis from the Time of Transplant Approval.
    Rodríguez-Arbolí E; Márquez-Malaver FJ; Rodríguez-Torres N; Caballero-Velázquez T; Escamilla-Gómez V; Calderón-Cabrera C; Falantes-González JF; Solé-Rodríguez M; García-Ramírez P; Moya-Arnao M; Carreras E; Espigado-Tocino I; Pérez-Simón JA
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):183-190. PubMed ID: 30153492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow.
    Barker JN; Krepski TP; DeFor TE; Davies SM; Wagner JE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2002; 8(5):257-60. PubMed ID: 12064362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China.
    Liu QF; Xu XJ; Chen YK; Sun J; Zhang Y; Fan ZP; Xu D; Jiang QL; Wei YQ; Huang F; Feng R; Liu XL; Xu B; Meng FY
    Ann Hematol; 2011 Mar; 90(3):331-41. PubMed ID: 20872002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic stem cell transplantation from unrelated donors in acute leukaemia.
    Lozano Cerrada S; Altaf SY; Olavarria E
    Curr Opin Oncol; 2018 Nov; 30(6):418-424. PubMed ID: 30222641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
    Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
    Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Optimized Search Prognosis Tool to Predict 8/8 HLA Allele-Matched Unrelated Donor Procurement.
    Davis E; Archer A; Flynn J; Nhaissi M; Rapoport C; Suri B; Wells D; Papadopoulos E; Politikos I; Fingrut WB; Scaradavou A; Barker JN
    Transplant Cell Ther; 2023 May; 29(5):312.e1-312.e5. PubMed ID: 36822475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unrelated donor hematopoietic cell transplantation: factors associated with a better HLA match.
    Dehn J; Arora M; Spellman S; Setterholm M; Horowitz M; Confer D; Weisdorf D
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1334-40. PubMed ID: 19041054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation.
    Ponce DM; Zheng J; Gonzales AM; Lubin M; Heller G; Castro-Malaspina H; Giralt S; Hsu K; Jakubowski AA; Jenq RR; Koehne G; Papadopoulos EB; Perales MA; van den Brink MR; Young JW; Boulad F; Kernan NA; Kobos R; Prockop S; Scaradavou A; Small T; O'Reilly RJ; Barker JN
    Biol Blood Marrow Transplant; 2011 Sep; 17(9):1316-26. PubMed ID: 21232625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.